Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to ease the heavy load on caregivers of young psychosis patients

NCT ID NCT07041463

Symptom relief Sponsor: Hôpital le Vinatier Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new psychoeducation program led by an advanced practice nurse to reduce the burden on family caregivers of young adults (ages 18-35) who have had a first psychotic episode. The program includes individual and group sessions to support caregivers. Researchers will measure changes in caregiver burden, mood, and other outcomes over 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Nov 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Caregiver relative of a patient under the care of the FEP team and meeting the criteria of international recommendations of FEP diagnosis made by the specialized team of less than 6 months, between 18 and 35 years of age. * Caregiver having received information about the study and having giveń consent. * Caregiver covered by a health insurance plan Exclusion Criteria: * Caregiver under curatorship, guardianship, safeguard of justice, family habilitation or future protection mandate * Caregiver participating in another study that may interact with this one * Caregiver not fluent in French (comprehension/reading) * Caregiver who has already received psycho-education on FEP * Patient's opposition to caregiver's participation in research

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caregiver burden are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Caregiver Burden

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Caregiver burden First episode psychosis (FEP) Impact of A new psychoeducation program coordinated by an advanced practice nurse on the burden of family caregivers of patients with A first psychotic episode Nurse practitioners

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH le Vinatier

    RECRUITING

    Bron, 69678, France

  • CHRU de Brest - Hôpital de BOHARS,

    NOT_YET_RECRUITING

    Bohars, 29820, France

  • CHU de Nîmes

    NOT_YET_RECRUITING

    Nîmes, 30029, France

  • Groupe Hospitalier Marius Lacroix

    NOT_YET_RECRUITING

    La Rochelle, 17000, France

  • Hôpital La Colombière

    NOT_YET_RECRUITING

    Montpellier, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.